Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,111.56 846.31 210.74 -141.46 37.99 0.00 19.3264 -0.38 -1.0689 -22.9391 -0.09 -0.09 7.4416 - -
Maximum - - - - - - 465,034.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Karuna Therapeutics, Inc. KRTX 329.83 0.09 0.03% 1,283 vs. 971 12,599.00 0.00 -113.00 -111.00 -997.00 -3.0100 -26.2644 0.0000 0.0000 0.0000 -0.0908 -0.0852 18.6075 38.00
Blueprint Medicines Corporation BPMC 96.62 -3.25 -3.25% 430 vs. 609 6,137.00 96.00 89.00 -102.00 -2,250.00 1.4500 16.6530 0.0000 0.9168 0.9274 0.2869 0.0858 3.4266 63.00
Apellis Pharmaceuticals, Inc. APLS 29.26 -0.32 -1.08% 1,166 vs. 2,415 3,639.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 124.00
Cytokinetics, Incorporated CYTK 56.19 -2.43 -4.15% 1,032 vs. 1,187 6,631.00 0.00 -135.00 -127.00 -2,247.00 -1.3300 -13.7171 0.0000 -1.7916 -162.4467 0.3424 -0.1679 6.9796 118.00
IVERIC bio, Inc. ISEE 39.95 0.15 0.38% 10,801 vs. 4,945 5,512.00 0.00 -70.00 -50.00 -937.00 -0.5200 -11.8078 0.0000 0.0000 0.0000 -0.1480 -0.1151 15.2365 137.00
DICE Therapeutics, Inc. DICE 47.55 0.03 0.06% 4,332 vs. 1,753 2,270.00 0.00 -34.00 -30.00 -248.00 -0.7400 -15.7831 0.0000 0.0000 0.0000 -0.0671 -0.0632 25.6858 47.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for KRTX and its peers to uncover potential buy and sell opportunities.